36Kr was informed that Jiangzhong Pharmaceutical issued an announcement that it intends to acquire 51% of the equity of Hayes Pharmaceutical by way of equity transfer and capital increase, and the total amount of the transaction price is expected to be 220 million yuan, and the source of funds is the company's own funds.
Today, Pistons player Corey Joseph was interviewed by the media about the progress of teammate Killian Hayes. "Last year he experienced the pandemic and ...
10-27
On September 21, Gelonghui announced 600750.SH that the eighteenth meeting of the eighth board of directors of the company deliberated and passed the "Acquisition by Equity Transfer and Capital Increase"
10-27
Pistons Media Day was held today, and Pistons coach Dwyane Casey was interviewed by the media about Pistons player Killian Hayes. "Hayes will go through a ...
10-27
![Jiangzhong Pharmaceutical and Hais Pharmaceutical successfully signed a strategic restructuring agreement[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
On September 17, Gelonghui announced that Jiangzhong Pharmaceutical (600750.SH) announced that the company intends to acquire Jincheng Haisi Pharmaceutical Co., Ltd. ("Hais Pharmaceutical") by way of equity transfer and capital increase.
10-27
Today, Pistons player Killian Hayes was interviewed by the media and talked about his physical condition since his comeback. "With the constant playing, I'm finding myself back...
10-31
